by Sam P.K. Collins Posted on August 15, 2014 Updated: August 15, 2014
A new study has prompted calls for the federal government to strengthen its drug approval process.
by Tara Culp-Ressler Posted on August 15, 2014
There aren't actually any approved drugs to treat the deadly virus.
by Tara Culp-Ressler Posted on June 5, 2014 Updated: June 6, 2014
"Today, we’re saying enough is enough -- it’s time for these companies to end these irresponsible practices and be held accountable for their deceptive actions."
by Tara Culp-Ressler Posted on April 30, 2014
Global health officials aren't mincing words about the catastrophic effects of growing antibiotic resistance.
by Tara Culp-Ressler Posted on April 15, 2014
A new drug named Sovaldi costs $1,000 per pill, and insurers are calling the price tag "outrageous."
by Tara Culp-Ressler Posted on April 10, 2014 Updated: April 11, 2014
How America's pharmacists could put pressure on states to stop executing inmates.
by Tara Culp-Ressler Posted on February 28, 2014
Doctors are warning that "strep group B," which can lead to life-threatening infections in babies, may be growing resistant to the last-resort drug used to treat it.
by Lauren C. Williams Posted on January 6, 2014
A little-known company that collects your prescription drug information is trying to take its stock public.
by Tara Culp-Ressler Posted on December 17, 2013
GlaxoSmithKline has announced that it will end the controversial practice of paying doctors to endorse its drugs -- a move that could encourage other Big Pharma companies to follow suit.
by Tara Culp-Ressler Posted on December 11, 2013
Each year, 500,000 people are infected with a strain of the deadly disease that doesn't respond to the drugs typically used to treat it.